PMCTPharmaCountry
    Accueil

Analyse

Analyses approfondies des marchés pharmaceutiques, des chaînes d'approvisionnement, de la technologie et de la réglementation

#exchange rate ×

Analyse
30 août 2026•1 min de lecture
High Won Exchange Rate Affects Pharma & Bio Companies Differently
While a weak won usually boosts exporters, pharma and biotech firms see mixed effects as foreign revenue growth is offset by rising foreign‑currency costs for raw materials, debt and liabilities.
Analyse
30 août 2026•1 min de lecture
Supply Prices of Hydrasexan Antidiarrheal Raised Effective July 1
Korean Aebot and Samjin Pharma have sharply increased the supply price of the pediatric and adult antidiarrheal Hydrasexan due to raw‑material costs and exchange‑rate shifts.